Influence of endothelin-1 on clonidine-induced cardiovascular effects in anesthetized rabbits

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Lim, Dong Yoon ^a   Heo, Kyeong ^a   Choi, Cheol Hee ^a   Lee, Eun Wha ^a  

^a Chosun University   (South Korea)

Author keywords

Clonidine hypotension; Endothelin 1; Sarafotoxin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; ENDOTHELIN 1;

ANIMAL; ARTICLE; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; GENERAL ANESTHESIA; HEART RATE; HEMODYNAMICS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; RABBIT;

ADRENERGIC ALPHA-AGONISTS; ANESTHESIA, GENERAL; ANIMALS; BLOOD PRESSURE; CLONIDINE; ENDOTHELIN-1; HEART RATE; HEMODYNAMIC PROCESSES; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; RABBITS;

EID: 0031629180     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00037     Document Type: Article

References (33)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;322:411-5.
2. Yanagisawa M, Inoue A, Ishikawa T, et al. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 1988;85:6964-7.
3. De Nucci G, Thomas R D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-800.
4. Sakata K, Ozaki H, Kwon S-C, Karaki H. Effects of endothelin on the mechanical activity and cytosolic calcium levels of various types of smooth muscle. Br J Pharmacol 1989;98:483-92.
5. Randall MD, Douglas SA, Hiley CR. Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat. Br J Pharmacol 1989;8:685-99.
6. Warner AG, de Nucci G, Vane JR. Endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol 1989; 159:325-6.
7. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 1987;327:524-6.
8. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (London) 1988; 333:664-6.
9. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 1984;24: 175-97.
10. Kuwaki T, Koshiya N, Terui N, Kumada M. Endothelin-1 modulates cardiorespiratory control by the central nervous system. Neurochem Int 1991;18:519-24.
11. Myatt L, Brewer AS, Brockman DE. The comparative effects of big endothelin-1, endothelin-1, and endothelin-3 in the human fetal-placental circulation. Am J Obstet Gynecol 1992;199:201-7.
12. Gulati A, Rebello S, Roy S, Saxena PR. Cardiovascular effects of centrally administered endothelin-1 in rats. J Cardiovasc Pharmacol 1995;26(suppl 3):S244-6.
13. Bousquet P, Schwanz J. α-Adrenergic drugs: pharmacological tools for the study of the central cardiovascular control. Biochem Pharmacol 1983;32:1459-65.
14. Bouquet P, Feldman J, Bloch R, Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: Differences between catecholamines and imidazolines. J Pharmacol Exp Ther 1984;230:232-6.
15. Granata AR, Numao Y, Kumada M, Reis DJ. α1 noradrenergic neurons tonically inhibit sympathoexcitatory neurons of the C1 area in rat brainstem. Brain Res 1986;377:127-46.
16. Punnen S, Urabanski R, Krieger AJ, Sapru HN. Ventrolateral medullary pressor area: site of hypotensive action of clonidine. Brain Res 1987;422:336-46.
17. Kobinger W. Central α-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 1988;81:39-100.
18. Guyenet PG, Cabot JH. Inhibition of sympathetic preganglinonic neurons by catecholamines and clonidine: mediation by an α-adrenergic receptor. J Neurosci 1981;1:90813.
19. 2-Adrenoceptors: classification, localization, mechanisms and targets for drugs. J Med Chem 1982;25:1389-401.
20. Gulati A, Rebello S. Down-regulation of endothelin receptors in the ventrolateral medulla of spontaneously hypertensive rats. Life Sci 1991;48:1207-12.
21. 2-adrenoceptors in ventrolateral medulla of spontaneously hypertensive rats. Life Sci 1991;48: 1199-203.
22. Gulati A, Srimal RC. Endothelin antagonizes the hypotension and potentiates the hypertension induced by clonidine. Eur J Pharmacol 1993;230:293-300.
23. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanisms of endothelin regulation. Implications for vascular function. Circulation 1991;84:1457-68.
24. Yoshida K, Kawano Y, Yoshimi H, Kuramochi M, Omae T. Blood pressure responses to intravenous or intracerebroventricular endothelin-1 in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1991;17(suppl 7):S297-9.
25. B-mediated blood pressure responses in rats. J Pharmacol Exp Ther 1994;270:728-33.
26. Takayanagi R, Kitazumi K, Takasaki C, et al. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett 1991;82:103-6.
27. B-like receptors. Biochem Biophys Res Commun 1992;184:100-6.
28. Sudajarwo SA, Hori M, Karaki H. Effect of endothelin-3 on cytosolic calcium level in vascular endothelium and on smooth muscle contraction. Eur J Pharmacol 1992;229:137-42.
29. Teerlink JR, Breu V, Sprecher U, Clozel M, Clozel JP. Potent vasoconstriction by endothelin ETB receptors in canine coronary arteries. Circ Res 1994;74:105-14.
30. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cyclic GMP. Circ Res 1983;52:352-7.
31. Ignarro LJ, Kadowitz PJ. Pharmacological and physiological role of cGMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 1985;25:171-91.
32. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 1986;78:1-5.
33. Waldaman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev 1987;39:163-96.